We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Hoefer Launches Range of ULTima Imaging Systems

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Hoefer Launches Range of ULTima Imaging Systems"

Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Hoefer Inc., has introduced the ULTima imaging platform, incorporating the latest advances in electronics and optics designed to provide a versatile and readily upgradeable gel documentation system with dynamic range for applications in proteomics and genomics.

ULTima’s image positioning system uses patented optics to enable simple positioning with no loss of optical resolution and no need to open the cabinet or manually adjust a fragile gel. The slant-correction feature permits optical rotation of the sample by ± 5 degrees for optimum lane detection, without touching the gel.

Another advantage of the range is that each of the four models – ULTima 10si, 16si, 16si Plus and Pro – is fully upgradeable to higher specifications as research needs change.

The versatile ULTima offers true multi-fluorophore capabilities and supersensitivity, performing chemiluminescent imaging and faint-band fluorescent detection. The filter changer accommodates up to five filters, while an optional Optix epi-illumination module enables excitation of fluorophores within the VIS/NIR range.

According to Ramana Tadepalli, Director of Sales and Marketing, Hoefer, Inc., ‘ULTima is meeting a widespread need for an imaging system which is fast, highly resolving and easy to use for applications in life science, clinical, pharmaceutical, agro, veterinary and forensic labs. Being fully equipped for GLP validation and verification, ULTima provides the comprehensive results documentation and complete integrity of data required in drug discovery and genetic engineering research.’